A 36-year-old man presented with near-syncope. He was found to have massive pericardial effusion with a giant pericardial tumorous lesion. The pericardial effusion exhibited a bloody nature; however, neither malignant cells nor infectious organisms were detected.
Introduction
Malignancy is a common cause of pericardial effusion, which can result from either pericardial malignancy or a non-malignant disease process, such as radiation pericarditis or opportunistic infections (1) . Cardiac tamponade may also be present, occurring at a rate of approximately 2-15% in patients with idiopathic pericarditis and a rate of approximately 60% in patients with neoplastic pericarditis (2). Ma et al. recently reported that malignancy (39%) and tuberculosis (27%) are the most common causes of large areas of pericardial effusion requiring drainage in Chinese patients and that cancer cells in the pericardial fluid are negative in approximately one-fourth of patients with malignant pericardial effusion (3) . Compared with lesions of a metastatic etiology, primary pericardial tumors, including mesotheliomas, fibrosarcomas, angiosarcomas, teratomas, hemangiomas, neurofibromas and lipomas, are considered to be extremely rare (4) . We herein report the case of a 36-year-old man who presented with cardiac tamponade symptoms caused by primary pericardial synovial sarcoma. 
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ties. A chest roentgenogram showed cardiomegaly with a cardiothoracic ratio of 62% (Fig. 1A) . Electrocardiography disclosed sinus tachycardia; however, the voltage was not low (Fig. 1B) . Echocardiography demonstrated massive pericardial effusion and a solid tumor that was neighboring the anterior wall of the left ventricle ( Fig. 2A, arrow) . Computed tomography (CT) further revealed massive pericardial effusion with a small amount of bilateral pleural effusion (Fig. 2B, C) . The tumor appeared to be located in the pericardial space, with an estimated size of 7.0×4.8 cm. On contrast-enhanced CT, the presence of arteries feeding the tumor originating from the left coronary artery was suspected ( Fig. 2C, arrows) and further confirmed on a reconstruction image of coronary CT (Fig. 2D, arrowheads) . Cardiac magnetic resonance imaging also showed a large amount of pericardial effusion, which was therefore sugges- 
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tive of hematoma owing to an inhomogeneous high signal intensity lesion on a T1-weighted image (Fig. 2E) . Laboratory studies showed a white blood cell count of 10,880 cells/μL, a hemoglobin level of 14.2 g/dL, a platelet count of 23.2×10 4 cells/μL, a C-reactive protein concentration of 4.91 mg/dL and a D-dimer level of 1.9 μg/mL. The serum soluble interleukin 2 receptor level was 320 U/mL. Owing to the patient's progressive symptoms and the compression of the right atrium, pericardiocentesis was performed on the day of admission. Bloody fluid containing 5.2 g/dL of hemoglobin was drawn from the pericardial sac. The drainage tube was removed on the sixth hospital day; up to that point, a total of 1,200 mL of fluid was withdrawn. The pericardial fluid was cytologically tested twice; however, no malignant cells were detected on either test.
Cardiac catheterization performed on the seventh hospital day showed preserved systolic contractility (cardiac index: 3.37 L/min/min 2 ) and a pulmonary capillary wedge pressure of 15 mmHg. Coronary angiograms showed no apparent coronary artery stenosis (Fig. 3) , with small arteries feeding the tumorous lesion (Fig. 3B, arrowheads) , as observed on coronary CT. Left ventriculography did not show any leakage of the contrast medium to the pericardial space. 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) showed an abnormal uptake in the pericardial region corresponding to the tumor; however, no distant hypermetabolic lesions were observed (Fig. 4) .
A surgical approach was taken for further diagnosis and management. Through a median sternotomy and midpericardial incision, the tumor was observed to be located 
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on the right ventricle (RV) anterior wall between the parietal and visceral pericardium (Fig. 5 ). Due to adhesion of the tumor to the parietal pericardium, dissection from the parietal pericardium was limited; thus, it was not possible to see the extension to the tumor on the left side. Moreover, the tumor strongly adhered to the visceral pericardium over the left anterior descending coronary artery from the right ventricular to the left ventricular anterior wall and appeared to invade the myocardium. Because the tumor exhibited hypervascularity, tissue sampling of even a small amount of the lesion caused bleeding. Based on an intraoperative histological examination of the tumor with malignant features and the intraoperative observations, the mass could not be resected.
A histological analysis showed fibroblast-like spindle cells with mitotic figures (Fig. 6A, B) . As a result, the tumor was diagnosed to be a spindle cell-type sarcoma. An immunohistochemical analysis showed that the tumor cells were positive for factor p53 and the Ki-67 proliferative index was 22.7% (Fig. 6C) ; however, staining for S100 proteins, CD34, CD31, α-smooth muscle antigens, muscle-specific actin (HHF35) and desmin was negative (data not shown). These immunological characteristics suggested that the possibility of angiosarcoma, rhabdomyosarcoma or leiomyosarcoma was rather remote. On the other hand, bcl-2 ( Fig. 6D ) and CD99 (Fig. 6E) were positive, and fluorescence in situ hybridization revealed a high prevalence (89.9%) of cells with interruption of the SYT gene (Fig. 6F, arrows) . Therefore, a diagnosis of monophasic synovial sarcoma with poorly differentiated areas was made (5), and the patient was started on adriamycin-based chemotherapy. Table. Cases 
Discussion
We herein reported a patient who was referred to our hospital due to symptoms of cardiac tamponade. He was found to have a large bloody pericardial effusion and pericardial mass that was diagnosed to be a pericardial synovial sarcoma due to its histologic characteristics, including rearrangement of the SYT gene.
Soft tissue sarcoma is a rare malignancy, comprising less than 1% of malignant neoplasms; this proportion may be much less (<0.01%) in the thorax (6) . In a previous study, synovial sarcoma was reported to account for 5% of 12,370 primary soft tissue sarcomas (7) . Synovial sarcoma has also been reported to account for 5-10% of all soft tissue sarcomas, occurring primarily in young adults between 15 and 35 years of age (8) . The tumors are classified into three histologic subtypes: monophasic, biphasic and poorly differentiated (9). The histologic type was judged to be monophasic in the current case.
Although immunological characteristics, such as positivity for bcl-2 and CD99, are not exclusive to synovial sarcoma, a definitive diagnosis can be made based on the presence of the chromosomal change t(X;18)(p11;q11), the cytogenetic hallmark of synovial sarcoma. The SS18 gene on 18q and either the SSX1 or SSX2 gene on Xp undergo reciprocal translocation, forming a fusion gene, SS18-SSX, with the subsequent production of fusion proteins; more than 90% of synovial sarcomas present with this characteristic molecular signature (10) . In addition, biphasic synovial sarcoma has an SYT-SSX1 fusion transcript, whereas SYT-SSX2-positive tumors are monophasic synovial sarcomas (8) . Unfortunately, we did not analyze either SSX1 or SSX2 involvement in the tumor in the present case.
Despite our search for potential primary malignant lesions on CT, MRI and FDG-PET, no such lesions could be found; therefore, the pericardial tumor was considered to be the primary lesion of the synovial sarcoma. In a search of PubMed (http://www.ncbi.nlm.nih.gov/pubmed/) entering the key words "synovial," "sarcoma" and "pericardium," only 31 hits were returned at the time point of August, 2013. Checking these papers, as well as the articles cited within, we found only 23 cases of synovial sarcoma that had been reported to arise from the pericardium (Table) . Due to its extreme rarity, the most effective therapeutic strategy for treating pericardial synovial sarcoma could not be determined, and the complete or near total excision of the tumor was performed in only four of the reported cases (17%). The pericardial tumor observed in the present case was also considered to be unresectable, due to its strong attachment to the visceral pericardium. Myers et al. experienced a 37-year-old man in whom complete resection was impossible due to diffuse infiltration of the epicardium (11) . That patient died 15 days after surgery, and the authors questioned whether the choice to attempt resection of the pericardial synovial sarcoma was beneficial. On the other hand, only a few cases of unresectable primary mediastinal synovial sarcoma have been reported (6); thus, the optimal strategy for treating unresectable synovial sarcomas, as well as the efficacy of adjuvant chemotherapy in such cases, remains to be established.
Pericardial involvement has been reported to be the first sign of malignancy in approximately one-third of patients with neoplastic tamponade. Atar et al. reported that, currently, malignancy, acute myocardial infarction and idiopathic disease are the predominant causes of non-iatrogenic cardiac tamponade resulting from bloody pericardial effusion in the United States and that hemorrhagic tuberculous pericardial effusion is becoming uncommon (12) . Wang et al. reported that, among 112 patients with cardiac tamponade, 65 (58%) had bloody effusion, 47 cases of which were due to malignancy, although the tamponade cases included those with an iatrogenic cause (13) . The authors found that more than half of the 112 patients had malignancies, with either the lung or breast being the most frequent origin of the neoplasms. Although the possibility and effectiveness of performing surgical resection for cardiac sarcoma may be limited, several chemo-and radiotherapy regimens have been reported to be effective for controlling the disorder (14, 15) .
In summary, we herein documented the case of a 36-yearold man with a primary pericardial synovial sarcoma and bloody pericardial effusion that caused symptoms of cardiac tamponade. A histological analysis showed CD99 positivity and SYT gene rearrangement, and a diagnosis of pericardial synovial sarcoma was made. The histological characteristics of the tumor, the clinical course of the patient and the response to chemotherapy should be carefully analyzed in order to establish the optimal therapeutic strategies for treating such extremely rare conditions in future cases.
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